动脉粥样硬化血栓形成性疾病中的抗血小板药物。
Antiplatelet agents in atherothrombotic diseases.
作者信息
Rao U, Weston C
机构信息
Department of Cardiology, Singleton Hospital, Swansea SA2 8QA.
出版信息
Hosp Med. 2004 Feb;65(2):72-5. doi: 10.12968/hosp.2004.65.2.12057.
Abstract
Atherothrombotic disease places a huge financial and social burden on the nation, and antiplatelet therapy is important in preventing this. Aspirin is most widely used but newer compounds are valuable, especially on top of standard therapy in patients with unstable angina or non-ST segment elevation myocardial infarction. This article reviews the changing use of antiplatelets.
摘要
动脉粥样硬化血栓形成性疾病给国家带来了巨大的经济和社会负担，而抗血小板治疗对于预防此类疾病至关重要。阿司匹林是使用最广泛的药物，但新型化合物也具有重要价值，尤其是在不稳定型心绞痛或非ST段抬高型心肌梗死患者的标准治疗基础上使用时。本文综述了抗血小板药物使用情况的变化。
相似文献
1
Antiplatelet agents in atherothrombotic diseases.动脉粥样硬化血栓形成性疾病中的抗血小板药物。
Hosp Med. 2004 Feb;65(2):72-5. doi: 10.12968/hosp.2004.65.2.12057.
2
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.脑血管疾病、冠状动脉疾病和外周动脉疾病中的口服抗血小板治疗。
JAMA. 2004 Oct 20;292(15):1867-74. doi: 10.1001/jama.292.15.1867.
3
The use of antiplatelet agents in acute cardiac care.抗血小板药物在急性心脏护理中的应用。
Crit Care Clin. 2001 Apr;17(2):365-77, vii. doi: 10.1016/s0749-0704(05)70172-x.
4
Antiplatelet medications and their indications in preventing and treating coronary thrombosis.抗血小板药物及其在预防和治疗冠状动脉血栓形成中的适应症。
Ann Med. 2000 Nov;32(8):561-71. doi: 10.3109/07853890008998836.
5
Antiplatelet drugs.抗血小板药物。
Med J Aust. 2003 Jun 2;178(11):568-74. doi: 10.5694/j.1326-5377.2003.tb05361.x.
6
[Antiplatelet agents--problem for cardiac surgeon].[抗血小板药物——心脏外科医生面临的问题]
Kardiol Pol. 2006 Nov;64(11):1329-31.
7
Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?不稳定型心绞痛的抗血小板治疗：阿司匹林、氯吡格雷、糖蛋白IIb/IIIa拮抗剂，还是三者联合使用？
Heart. 2002 Jul;88(1):11-4. doi: 10.1136/heart.88.1.11.
8
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.依替巴肽在已接受阿司匹林和氯吡格雷治疗的非ST段抬高型心肌梗死患者中可提供额外的血小板抑制作用。阿司匹林、氯吡格雷和依替巴肽用于非Q波心肌梗死患者血小板活性消除的研究（PEACE研究）结果。
J Am Coll Cardiol. 2004 Jan 21;43(2):162-8. doi: 10.1016/j.jacc.2003.08.033.
9
Antiplatelet agents in stroke prevention. combination therapy: present and future.预防卒中的抗血小板药物。联合治疗：现状与未来。
Cerebrovasc Dis. 2000;10 Suppl 5:41-8. doi: 10.1159/000047603.
10
Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Cerebrovasc Dis. 2000;10 Suppl 5:34-40. doi: 10.1159/000047602.
Zotero 插件